Lenape Regional High School District Counselor - School Medicare: Not Enrolled in Medicare Practice Location: 93 Willow Grove Rd, Shamong, NJ 08088 Phone: 609-268-2000 Fax: 609-268-8971 |
Aspire Clinical Training Center Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 212 Skylar Ct, Shamong, NJ 08088 Phone: 856-279-0020 |
Tranquil Pines Counseling Llc Counselor - Professional Medicare: Medicare Enrolled Practice Location: 411 Kaila Ct, Shamong, NJ 08088 Phone: 609-401-2012 |
Oaks Integrated Care Clinic - Adult Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1390 Old Indian Mills Rd, Shamong, NJ 08088 Phone: 609-267-5928 |
News Archive
The Society of Interventional Radiology Foundation's Discovery Campaign, which seeks to further the growth of minimally invasive medicine into new areas of discovery, announced a major corporate pledge to that initiative. Boston Scientific, a global leader in medical devices for cardiovascular and peripheral interventions, pledged $100,000 and is a "Pioneer" level supporter.
In October 2008 the province's Health Quality Council released its first "state of health care quality" report, called Quality Insight. Key messages in that inaugural report were that limited access to timely data and the absence of an electronic health record were making it hard for HQC, health providers, and system leaders to improve health care for Saskatchewan patients.
After more than a year of debate, state regulators ... approved a resolution calling for changes to the healthcare reform law's medical loss ratio provision. The National Association of Insurance Commissioners (NAIC) passed the measure 26-20, over strenuous objections from commissioners who said the process and the resolution itself would undermine the NAIC's reputation.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of gastric cancer, Roche/Genentech/ Chugai's Herceptin as an add-on to standard chemotherapy earns Decision Resources' proprietary clinical gold standard status in 2013, following its approval for the first-line treatment of human epidermal growth factor receptor 2 (HER2)-positive gastric cancer in 2010.
› Verified 6 days ago